Fundraising Fox
Katrine Bosley
InvestorVenture Partner at Advent Life Sciences · Board director at Genocea Biosciences
Find your path to Katrine
39 people in our graph can introduce you to Katrine.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Josh Wolfe to introduce you to Katrine
You →Josh · together at Genocea Biosciences →Katrine
Ask Jamie Chen to introduce you to Katrine
You →Jamie · 2 people · together at Genocea Biosciences →Katrine
Ask Sam Okafor to introduce you to Katrine
You →Sam · 9 people · together at Advent Life Sciences →Katrine
Sign up to find every way you can get introduced to Katrine
- Your email: the people you already email who know Katrine
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Katrine
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Katrine Bosley is a biotech entrepreneur with over 30 years in the industry. She was CEO of Editas Medicine, which she led from its early stages through its IPO and into clinical development of the first in vivo CRISPR-based medicine, and previously served as CEO of Avila Therapeutics through its acquisition by Celgene. Earlier in her career she was Entrepreneur-in-Residence at The Broad Institute, VP of Business Development at Adnexus Therapeutics/Bristol Myers-Squibb, and held roles at Biogen, Highland Capital Partners, and Alkermes; she is a Cornell University graduate.
Invests in
Biotech
Board director at Genocea Biosciences
Intro paths
In turn, Katrine can intro founders to Genocea Biosciences's investors below.
Genocea Biosciences's investors · 8
Deals · 1
Genocea BiosciencesBoard seat
via Advent Life Sciences · filed Feb 2019 · $15M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
DaCapo Brainscience
Sources: the firm's website · SEC Form D filings.
Colleagues at Advent Life Sciences
Frequently asked questions
- Who is Katrine Bosley?
- Katrine Bosley is a biotech entrepreneur with over 30 years in the industry. She was CEO of Editas Medicine, which she led from its early stages through its IPO and into clinical development of the first in vivo CRISPR-based medicine, and previously served as CEO of Avila Therapeutics through its acquisition by Celgene. Earlier in her career she was Entrepreneur-in-Residence at The Broad Institute, VP of Business Development at Adnexus Therapeutics/Bristol Myers-Squibb, and held roles at Biogen, Highland Capital Partners, and Alkermes; she is a Cornell University graduate.
- Where does Katrine Bosley work?
- Katrine Bosley is Venture Partner at Advent Life Sciences and Board director at Genocea Biosciences.
- What does Katrine Bosley invest in?
- Katrine Bosley invests in Biotech.
- What boards does Katrine Bosley sit on?
- Katrine Bosley holds tracked board seats at Arrakis Therapeutics, Genocea Biosciences, Genocea Biosciences.
- What companies has Katrine Bosley invested in?
- Investments tracked here include DaCapo Brainscience.